Tenora Chem Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 2.78 Cr
as on 19-12-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.25 Cr
as on 19-12-2024
- Revenue 11.30%
(FY 2020)
- Profit -352.79%
(FY 2020)
- Ebitda -112.24%
(FY 2020)
- Net Worth -41.52%
(FY 2020)
- Total Assets 16.92%
(FY 2020)
About Tenora Chem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.78 Cr.
The company currently has active open charges totaling ₹1.25 Cr.
Ravi Subramaniam, Murali Attilli, Douglas David, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110MH2014PTC260117
- Company No.
260117
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Dec 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Tenora Chem Private Limited offer?
Tenora Chem Private Limited offers a wide range of products and services, including Printing Inks & Other Supplies, Printer Consumables.
Who are the key members and board of directors at Tenora Chem?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murali Attilli  | Director | 11-Dec-2014 | Current |
| Douglas David | Director | 25-Jul-2022 | Current |
| Ravi Subramaniam | Director | 11-Dec-2014 | Current |
| Jaishankar Sthanumurthy | Director | 11-Dec-2014 | Current |
Financial Performance of Tenora Chem.
Tenora Chem Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 11.3% increase. The company also saw a substantial fall in profitability, with a 352.79% decrease in profit. The company's net worth observed a substantial decline by a decrease of 41.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tenora Chem?
In 2020, Tenora Chem had a promoter holding of 99.87% and a public holding of 0.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 23 Jan 2024 | ₹1.25 Cr | Open |
How Many Employees Work at Tenora Chem?
Tenora Chem has a workforce of 32 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tenora Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tenora Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
